What amount sold does iQure Pharma Inc. report in Form D filings?

The latest linked filings report $6.6M sold across 5 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was iQure Pharma Inc.'s most recent SEC filing?

iQure Pharma Inc.'s most recent Form D filing was on 2026-09-21.

How many investors does iQure Pharma Inc. have?

The most recent Form D filing lists 18 investor(s).

What type of securities does iQure Pharma Inc. offer?

iQure Pharma Inc.'s SEC Form D filings indicate equity offerings.

iQure Pharma Inc.

CIK: 0001996977·Other·SKILLMAN, NJ·Corporation

Reported Sold

$6,602,101

Total Filings

Identified Offerings

Last Filed

Sep 21, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other industry

SEC EDGAR

Offering filing timeline

Sep 21, 2026Form D/A — Amendment

Reported sold: $2,788,315 · Target: $4,000,000

Rule 506(b)·18 investors

Changed: Reported amount sold, Offering target, Reported investors

Jun 3, 2026Form D — New notice

Reported sold: $650,000 · Target: $4,000,000

Rule 506(b)·1 investor

Nov 3, 2025Form D — New notice

Reported sold: $1,503,320 · Target: $1,750,000

Rule 506(b)·14 investors

Jan 16, 2025Form D — New notice

Reported sold: $1,443,786 · Target: $1,443,786

Rule 506(b)·2 investors

Apr 16, 2024Form D — New notice

Reported sold: $220,000 · Target: Indefinite

Rule 506(b)·7 investors

Oct 11, 2023Form D — New notice

Reported sold: $1,500,000 · Target: $2,000,000

Rule 506(b)·13 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

17%

Latest reported sold across 5 identified offerings

$6,602,101

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Pawel Zolnierczyk

Related Person

Appears on 3 filings

Pawel Zolnierczyk

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 21, 2026	Amendment	$4,000,000	$2,788,315	18
Jun 3, 2026	New	$4,000,000	$650,000	1
Nov 3, 2025	New	$1,750,000	$1,503,320	14
Jan 16, 2025	New	$1,443,786	$1,443,786	2
Apr 16, 2024	New	Indefinite	$220,000	7
Oct 11, 2023	New	$2,000,000	$1,500,000	13

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

CORE X Partners LLC

Other

Offering target: $3,524,992

Filed Oct 20, 2026